{"title":"A Novel Neuroprotective Cholinesterase and Brain-Selective MAO Inhibitor with APP Processing Activity for the Treatment of Dementia Co-morbid with Depression and Parkinson's Disease","authors":"M. Youdim, M. Weinstock","doi":"10.1111/J.1527-3458.2004.TB00013.X","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10499,"journal":{"name":"CNS drug reviews","volume":"34 1","pages":"191-191"},"PeriodicalIF":0.0000,"publicationDate":"2006-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CNS drug reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/J.1527-3458.2004.TB00013.X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A Novel Neuroprotective Cholinesterase and Brain-Selective MAO Inhibitor with APP Processing Activity for the Treatment of Dementia Co-morbid with Depression and Parkinson's Disease